BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
17.27
+0.14 (0.82%)
At close: Dec 5, 2025, 4:00 PM EST
17.50
+0.23 (1.33%)
After-hours: Dec 5, 2025, 6:36 PM EST
BrainsWay Revenue
BrainsWay had revenue of $13.51M in the quarter ending September 30, 2025, with 28.66% growth. This brings the company's revenue in the last twelve months to $49.09M, up 27.08% year-over-year. In the year 2024, BrainsWay had annual revenue of $41.02M with 29.04% growth.
Revenue (ttm)
$49.09M
Revenue Growth
+27.08%
P/S Ratio
6.80
Revenue / Employee
$409,117
Employees
120
Market Cap
333.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.02M | 9.23M | 29.04% |
| Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
| Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
| Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
| Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BWAY News
- 5 days ago - BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript - Seeking Alpha
- 11 days ago - BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025 - GlobeNewsWire
- 19 days ago - BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder - GlobeNewsWire
- 23 days ago - BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 - GlobeNewsWire
- 25 days ago - BrainsWay Ltd. (BWAY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 4 weeks ago - BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder - GlobeNewsWire
- 5 weeks ago - BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025 - GlobeNewsWire